SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001654954-23-007172
Filing Date
2023-05-24
Accepted
2023-05-24 16:54:11
Documents
7
Effectiveness Date
2023-05-24

Document Format Files

Seq Description Document Type Size
1 FORM S-8 edsa_s8.htm S-8 58295
2 OPINION edsa_ex51.htm EX-5.1 6771
3 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM edsa_ex232.htm EX-23.2 2647
4 FILLING FEE edsa_107.htm EX-FILING FEES 21218
5 edsa_ex51img1.jpg GRAPHIC 11238
6 edsa_ex232img3.jpg GRAPHIC 3175
7 edsa_ex232img4.jpg GRAPHIC 3721
  Complete submission text file 0001654954-23-007172.txt   115346
Mailing Address 100 SPY COURT MARKHAM A6 L3R 5H6
Business Address 100 SPY COURT MARKHAM A6 L3R 5H6 (905) 475-1234
Edesa Biotech, Inc. (Filer) CIK: 0001540159 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
Type: S-8 | Act: 33 | File No.: 333-272176 | Film No.: 23954885
SIC: 2834 Pharmaceutical Preparations